[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-(1,3-thiazol-5-yl)methanone
C20H20N6O2S — CID 137029379
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-(1,3-thiazol-5-yl)methanone
[3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-(1,3-thiazol-5-yl)methanone (PubChem CID 137029379) has the molecular formula C20H20N6O2S and a molecular weight of 408.49 g/mol. Its IUPAC name is [3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-(1,3-thiazol-5-yl)methanone.
Molecular Properties
| Compound Name | [3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-(1,3-thiazol-5-yl)methanone |
|---|---|
| PubChem CID | 137029379 |
| Molecular Formula | C20H20N6O2S |
| Molecular Weight | 408.49 g/mol |
| Exact Mass | 408.14 |
| IUPAC Name | [3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-(1,3-thiazol-5-yl)methanone |
| SMILES | Nc1nnc(-c2ccccc2O)cc1N1CC2CCC(C1)N2C(=O)c1cncs1 |
| InChI | InChI=1S/C20H20N6O2S/c21-19-16(7-15(23-24-19)14-3-1-2-4-17(14)27)25-9-12-5-6-13(10-25)26(12)20(28)18-8-22-11-29-18/h1-4,7-8,11-13,27H,5-6,9-10H2,(H2,21,24) |
| InChIKey | NTWYBAVHVOGHBD-UHFFFAOYSA-N |
| XLogP | 2.38 |
| TPSA | 108.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 408.49 |
| LogP ≤ 5 | 2.38 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137029379 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.